A pyrazolo-pyrimidinone based series of growth hormone secretagogue receptor type 1a (GHS-R1a) antagonists and inverse agonists were identified using a scaffold hop from known quinazolinone GHS-R1a modulators. Lipophilicity was reduced to decrease hERG activity while maintaining GHS-R1a affinity. SAR exploration of a piperidine substituent was used to identify small cyclic groups as a functional switch from partial agonists to neutral antagonists and inverse agonists. A tool compound was identified which had good overall properties and sufficient oral plasma and CNS exposure to demonstrate reduced food intake in mice through a mechanism involving GHS-R1a.
研究人员利用已知
喹唑啉酮类 GHS-R1a 调节剂的支架,鉴定了一系列基于
吡唑并
嘧啶酮的生长激素分泌受体 1a 型(GHS-R1a)拮抗剂和反向激动剂。在保持 GHS-R1a 亲和力的同时,降低了亲脂性以降低 hERG 活性。利用对
哌啶取代基的
SAR 探索,确定了从部分激动剂到中性拮抗剂和反向激动剂的功能转换小环状基团。最终确定了一种工具化合物,该化合物具有良好的整体特性和足够的口服血浆和中枢神经系统暴露量,可通过涉及 GHS-R1a 的机制证明小鼠的食物摄入量降低。